Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells.
Saved in:
| Title: | Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. |
|---|---|
| Authors: | Nguyen N; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany., Min Y; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany., Rivière J; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany., van der Garde M; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany., Ghosh S; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, United States of America., Bartos LM; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Bassermann F; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany., Azhdarinia A; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, United States of America., Weber WA; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Götze KS; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany., Kossatz S; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Chemistry, School of Natural Sciences, Technical University Munich, Munich, Germany. |
| Source: | Theranostics [Theranostics] 2025 May 25; Vol. 15 (13), pp. 6497-6515. Date of Electronic Publication: 2025 May 25 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40521188 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nguyen+N%22">Nguyen N</searchLink>; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Min+Y%22">Min Y</searchLink>; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Rivière+J%22">Rivière J</searchLink>; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22van+der+Garde+M%22">van der Garde M</searchLink>; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Ghosh+S%22">Ghosh S</searchLink>; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, United States of America.<br /><searchLink fieldCode="AU" term="%22Bartos+LM%22">Bartos LM</searchLink>; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Brendel+M%22">Brendel M</searchLink>; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Bassermann+F%22">Bassermann F</searchLink>; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Azhdarinia+A%22">Azhdarinia A</searchLink>; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, United States of America.<br /><searchLink fieldCode="AU" term="%22Weber+WA%22">Weber WA</searchLink>; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Götze+KS%22">Götze KS</searchLink>; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Kossatz+S%22">Kossatz S</searchLink>; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Chemistry, School of Natural Sciences, Technical University Munich, Munich, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2025 May 25; Vol. 15 (13), pp. 6497-6515. <i>Date of Electronic Publication: </i>2025 May 25 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40521188 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7150/thno.113354 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6497 Titles: – TitleFull: Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nguyen N – PersonEntity: Name: NameFull: Min Y – PersonEntity: Name: NameFull: Rivière J – PersonEntity: Name: NameFull: van der Garde M – PersonEntity: Name: NameFull: Ghosh S – PersonEntity: Name: NameFull: Bartos LM – PersonEntity: Name: NameFull: Brendel M – PersonEntity: Name: NameFull: Bassermann F – PersonEntity: Name: NameFull: Azhdarinia A – PersonEntity: Name: NameFull: Weber WA – PersonEntity: Name: NameFull: Götze KS – PersonEntity: Name: NameFull: Kossatz S IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 05 Text: 2025 May 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1838-7640 Numbering: – Type: volume Value: 15 – Type: issue Value: 13 Titles: – TitleFull: Theranostics Type: main |
| ResultId | 1 |
